Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients
ObjectiveThis study aims to develop and validate a nomogram model that integrates autoantibodies and systemic inflammation markers to predict the risk of bone metastases in patients with non-small cell lung cancer (NSCLC). Additionally, we propose a no…